ストックスクリーナーアプリを入手
8.87
7.78%
0.64
前日終値:
$8.23
開ける：
$8.05
24時間の取引高:
1.22M
Relative Volume:
0.37
時価総額：
$628.89M
収益：
-
当期純損益:
$-117.81M
株価収益率:
-4.7181
EPS:
-1.88
ネットキャッシュフロー:
$74.30M
1週間 パフォーマンス:
+12.71%
1か月 パフォーマンス:
+12.71%
6か月 パフォーマンス:
+185.21%
1年 パフォーマンス:
+14.75%
1日の値動き範囲:
$8.04
$8.91
1週間の範囲:
$7.72
$9.55
52週間の値動き範囲:
$2.95
$13.60
Omeros Corporation Stock (OMER) Company Profile
名前
Omeros Corporation
セクター
電話
206-676-5000
住所
201 ELLIOTT AVENUE WEST, SEATTLE, WA
OMER を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OMER
Omeros Corporation
|
8.87 | 583.51M | 0 | -117.81M | 74.30M | -1.88 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Omeros Corporation Stock (OMER) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-10 | 開始されました | H.C. Wainwright | Buy |
| 2024-12-23 | 開始されました | D. Boral Capital | Buy |
| 2024-11-14 | 開始されました | Rodman & Renshaw | Buy |
| 2022-12-08 | ダウングレード | UBS | Buy → Neutral |
| 2022-11-08 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-06-08 | ダウングレード | BofA Securities | Buy → Neutral |
| 2021-10-08 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2021-10-01 | ダウングレード | Maxim Group | Buy → Hold |
| 2021-10-01 | ダウングレード | Wedbush | Neutral → Underperform |
| 2021-09-27 | 開始されました | JP Morgan | Neutral |
| 2021-02-01 | 開始されました | UBS | Buy |
| 2020-10-20 | 開始されました | BofA Securities | Buy |
| 2020-08-21 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-08-14 | 繰り返されました | Maxim Group | Buy |
| 2019-05-06 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-07-12 | 開始されました | Seaport Global Securities | Buy |
| 2018-03-23 | ダウングレード | Wedbush | Outperform → Neutral |
| 2018-03-05 | ダウングレード | Needham | Buy → Hold |
| 2017-11-08 | 開始されました | H.C. Wainwright | Buy |
| 2017-05-11 | ダウングレード | Cantor Fitzgerald | Buy → Neutral |
| 2017-03-17 | 繰り返されました | Maxim Group | Buy |
| 2017-03-17 | 繰り返されました | Needham | Buy |
| 2016-11-16 | 繰り返されました | Wedbush | Outperform |
| 2016-11-10 | 繰り返されました | Needham | Buy |
| 2016-08-10 | 繰り返されました | Maxim Group | Buy |
| 2016-06-03 | 開始されました | Cantor Fitzgerald | Buy |
| 2016-03-02 | 繰り返されました | Needham | Buy |
| 2016-02-29 | 繰り返されました | Wedbush | Outperform |
| 2015-11-11 | 繰り返されました | Needham | Buy |
| 2015-08-18 | 繰り返されました | WBB Securities | Strong Buy |
| 2015-08-10 | 開始されました | ROTH Capital | Buy |
すべてを表示
Omeros Corporation (OMER) 最新ニュース
Omeros: Key Milestone Ahead, Risk-Averse Investors Should Avoid (NASDAQ:OMER) - Seeking Alpha
What technical signals suggest for Omeros Corporation stockMarket Performance Recap & Real-Time Volume Trigger Notifications - newser.com
Omeros Corporation Stock Analysis and ForecastInsider Selling Patterns & Free Stock Trading Workshops - earlytimes.in
Is Omeros Corporation stock cheap compared to fundamentalsIPO Watch & Technical Entry and Exit Tips - newser.com
Omeros gets FDA acceptance for narsoplimab BLA resubmission - MSN
Omeros (NASDAQ:OMER) Shares Down 5.6%Should You Sell? - MarketBeat
Here's Why Shares in Theravance Biopharma Exploded Today - AOL.com
Why Shares in Arrowhead Pharmaceuticals Surged on News of a Novartis Deal - AOL.com
How strong is Omeros Corporation stock revenue growthBuy Signal & Fast Exit/Entry Strategy Plans - newser.com
This Fund Sold $30 Million in PTC Therapeutics Shares Amid a 93% Rally: Here’s Why - AOL.com
Omeros (NASDAQ:OMER) Stock Price Up 8.1%Time to Buy? - MarketBeat
Omeros Corporation (NASDAQ:OMER) Q3 2025 Earnings Call Transcript - Insider Monkey
Centessa Stock Has Surged 77% Over the Past Year — But a Top Biotech Fund Is Still Buying - AOL.com
This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug Launch - AOL.com
Omeros Corporation’s Earnings Call Highlights Strategic Moves - TipRanks
test-commerce-234 - AOL.com
Omeros (OMER) Q3 2025 Earnings Call Transcript - The Globe and Mail
Published on: 2025-11-17 02:29:02 - newser.com
Omeros Corporation stock outlook for YEARJuly 2025 Selloffs & Precise Swing Trade Alerts - newser.com
D. Boral Capital Reiterates "Buy" Rating for Omeros (NASDAQ:OMER) - MarketBeat
What candlestick patterns are forming on Omeros CorporationWeekly Stock Summary & Proven Capital Preservation Methods - newser.com
Omeros (NASDAQ:OMER) Shares Gap UpHere's Why - MarketBeat
Is Omeros Corporation meeting your algorithmic filter criteriaMarket Activity Report & Real-Time Chart Breakout Alerts - newser.com
Ranking Omeros Corporation among high performing stocks via toolsJuly 2025 Highlights & Community Supported Trade Ideas - newser.com
Omeros (NASDAQ:OMER) Cut to Sell at Wall Street Zen - MarketBeat
Omeros files automatic mixed securities shelf - MSN
Omeros (NASDAQ:OMER) Announces Quarterly Earnings Results - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Omeros (OMER) Receives Analyst 'Buy' Rating with Stable Price Ta - GuruFocus
Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday - Benzinga
D. Boral Capital Maintains Omeros (OMER) Buy Recommendation - MSN
Omeros: Q3 Earnings Snapshot - CTPost
Omeros Corp (OMER) Q3 2025 Earnings Call Highlights: Strategic Moves and Financial Challenges By GuruFocus - Investing.com Canada
Can Omeros Corporation stock resist market sell offsOptions Play & Free Community Supported Trade Ideas - newser.com
Omeros Corp (OMER) Q3 2025 Earnings Call Highlights: Strategic Moves and Financial Challenges - Yahoo Finance
Omeros Corporation Reports Q3 2025 Financial Results - TipRanks
Applied Therapeutics, Omeros, And Others Post Sharp Moves After Market Close - Nasdaq
Omeros Sets Sights On Big Pharma Deal And FDA Green Light - Finimize
Omeros Inks Big Deal With Novo Nordisk And Eyes FDA Nod - Finimize
Omeros Q3 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Omeros Q3 2025 sees narrower loss, stock drops - Investing.com Nigeria
Omeros (OMER) Set for Transformative Growth with Key Developments - GuruFocus
Omeros Corp. R (3O8.F) Q3 FY2025 earnings call transcript - Yahoo Finance
BRIEF-Omeros Corporation Q3 EPS USD -0.47 - TradingView
Omeros Corporation Reports Third Quarter 2025 Financial Results - The Joplin Globe
Omeros Corporation (OMER) 財務データ
収益
当期純利益
現金流量
EPS
1.38%
1.42%
大文字化:
|
ボリューム (24 時間):